DAUNORUBICIN CITRATE LIPOSOME - INJECTION
PHONETIC PRONUNCIATION: (dawn-oh-REWB-eh-sin SIH-trate lye-poe-SEW-mull)
COMMON BRAND NAME(S): Daunoxome
GENERIC NAME(S): daunorubicin citrate liposomal
Uses
USES: This medication is used to treat a certain type of cancer (Kaposi's sarcoma). It belongs to a class of drugs known as anthracyclines and works by slowing or stopping the growth of cancer cells.
How to use DAUNORUBICIN CITRATE LIPOSOME - INJECTION
HOW TO USE: This medication is given by injection slowly into a vein by a health care professional. Dosage is based on your medical condition, body size, and response to treatment. If this medication accidentally leaks into the skin/muscle around the injection site, it may cause severe damage. Tell your doctor right away if you notice redness, pain, or swelling at or near the injection site. If this medication touches your skin, immediately wash the area well with soap and water. Caregivers should take precautions (e.g., wear gloves) to prevent contact with the patient's urine and other body fluids. Drink plenty of fluids while using this medication unless otherwise directed by your doctor. Doing so helps decrease the risk of certain side effects (e.g., increased uric acid).
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for DAUNORUBICIN CITRATE LIPOSOME - INJECTION
Daunorubicin Citrate Liposome Injection is used for the treatment of certain types of cancer, including advanced ovarian cancer and Kaposi's sarcoma in patients with AIDS.
Daunorubicin Citrate Liposome Injection works by interfering with the growth of cancer cells, preventing them from multiplying and spreading.
Common side effects of Daunorubicin Citrate Liposome Injection may include nausea, vomiting, diarrhea, mouth sores, hair loss, and decreased blood cell counts.
Daunorubicin Citrate Liposome Injection is given as an intravenous (IV) infusion, usually over a specific period of time determined by the healthcare provider.
Patients with liver or kidney problems, history of heart disease, pregnancy, or breastfeeding should use caution while taking Daunorubicin Citrate Liposome Injection. It may also increase the risk of developing secondary cancers.
The frequency of Daunorubicin Citrate Liposome Injection administration will depend on the specific type and stage of cancer being treated. Your healthcare provider will determine the appropriate dosage and schedule.
It is important to follow the treatment schedule as prescribed by your healthcare provider. If you miss a dose, contact your healthcare provider for further instructions.
Inform your healthcare provider about all the medications, including prescription, over-the-counter, and herbal supplements, you are taking. Some medications may interact with Daunorubicin Citrate Liposome Injection and affect its effectiveness or increase the risk of side effects.
The effectiveness and response time may vary depending on individual factors and the specific cancer being treated. Your healthcare provider will monitor your progress and response to the treatment.
Warning
WARNING: This medication may rarely cause serious (rarely fatal) heart problems (including heart failure). This may occur both during treatment or months to years after treatment is completed. The risk of heart problems is affected by your dose, medical history (including previous heart disease, radiation treatment to the chest area), and previous use of this and other drugs (including doxorubicin). Tell your doctor right away if you notice symptoms such as very fast/irregular heartbeat, shortness of breath, swelling ankles/feet, unusual tiredness, or unusual/sudden weight gain. Daunorubicin may cause certain severe blood and bone marrow disorders (low red blood cells/white blood cells/platelets). This can affect your body's ability to stop bleeding or fight infection. Tell your doctor right away if you develop easy bleeding/bruising or signs of infection (e.g., fever, chills, persistent sore throat). Very rarely, people with cancer who are treated with this type of medication have developed other cancers (e.g., secondary leukemia). The risk may be increased when this medication is given with certain anti-cancer drugs or radiation treatment. Consult your doctor for more details. Before starting treatment with this medication, tell your doctor if you have liver or kidney problems. Your dose may need to be adjusted. This medication may cause symptoms including back pain, flushing, and chest tightness, usually during the first 5 minutes of injection into a vein. If you notice any of these symptoms, tell your doctor or nurse right away. If the injection is temporarily stopped and then given more slowly, the symptoms will not usually return.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet